Managed Care & Value-Based Reimbursement – Madeline Shurtleff, PharmD

Listen to Amica Simmons-Yon, PharmD, PhD and Alyssa Peckham, PharmD, BCPP as they spill the tea on Managed Care & Value-Based Reimbursement with special guest, Madeline Shurtleff, PharmD. During this episode, Dr. Shurtleff highlights the difference between individual health plans and pharmacy benefit managers (PBMs), and how that differs among private insurers versus federal. She also tunes us into the inner workings of the two – namely, how they interact with one another and how decisions are made to deliver your health care. Lastly, Dr. Shurtleff let’s us know where we can find more information on managed care topics! Dr. Shurtleff graduated from the University of Rhode Island College of Pharmacy. She started her pharmacy career as a pharmacist at Walgreens before transitioning to managed care. Her managed care experience includes managing utilization management pharmacist teams for various Medicare, Medicaid, and Dual Eligible Special Needs Plan (D-SNP) health plans. As a Managed Market Liaison with Otsuka, she helps to bridge clinical, economic, and disease state information to support better health outcomes for patients. She resides in Phoenix, Arizona. Featuring: • Madeline Shurtleff, PharmD; Managed Market Liaison, OPDC • Amica Simmons-Yon, PharmD, PhD; Clinical & Scientific Liaison, OPDC • Alyssa Peckham, PharmD, BCPP; Clinical & Scientific Liaison, OPDC Links: PsychU Article | Ready, Set, Managed Care! https://bit.ly/3M6Oz4V PsychU Article | Medicaid Managed Care – From 0 To 100: https://bit.ly/3jLOeZv PsychU Interview | Mental Health & COVID-19: Managed Care Perspective: https://bit.ly/3jFWbzi PsychU Article | Collaboration Between Managed Care & Mental Health Staff: Does It Improve Outcomes? https://bit.ly/3xAsUOD PsychU Article | Medicare Managed Care Is On The Increase – At Consumer Request: https://bit.ly/3JRhk41 Madeline Shurtleff, Amica Simmons-Yon, and Alyssa Peckham are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC. US.CORP.X.22.00133